SABCS

During the San Antonio Breast Cancer Symposium last week, InVitae announced the commercial launch of a 29-gene next-generation sequencing test that doctors can use to learn their patients' risk for hereditary breast and ovarian cancer, but also a number of other hereditary cancer

Pages

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.